Bibliography
- VAN AKEN H: Ethics, economics and outcome. Can: Opin. Anaesthesia (1997) 10:145–146.
- •Editorial comment of ethics, economics, and outcome.
- GLASS PSA, GAN TJ, HOWELL S:A review of the pharmacokinetics and pharmakodynamics of remifentanil.Anesth. Analg. (1999) 89(45):57–514.
- •A review of the pharmacokinetics and pharmakodynarnics of remifentanil.
- WILHELM W, WROBEL M, KREUER S,LARSEN R: Remifentanil - EineBestandsaufnahme. Anaesthesist (2003) 52(6):473–494.
- •A review of the pharmacokinetics and pharmakodynarnics of remifentanil.
- JOSHI GP, WARNER DS, TWERSKY RS, FLEISCHER LA: A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter Phase IV study.Clin. Anesth. (2002) 14(7):494–499.
- ••A prospective, randomised, controlled trialcomparing remifentanil with fentanyl.
- CARTWRIGHT DP, KVALSBVIK 0, CASSUTO J et al.: A randomized, blind comparison of remifentanil and alfentanil during anesthesia for outpatient surgery. Anesth. Analg. (1997) 85:1014–1019.
- •A prospective, randomised, controlled trial comparing remifentanil with alfentanil.
- CASATI A, ALBERTIN A, FANELLI Get al.: A comparison of remifentanil and sufentanil as adjuvants during sevoflurane anesthesia with epidural analgesia for upper abdominal surgery: effects on postoperative recovery and respiratory function.Anesth. Analg. (2000) 91:1269–1273.
- •A prospective, randomised, controlled trial comparing remifentanil with sufentanil.
- SAVARESE JJ, LIEN CA,BELMONT MR, WASTILA WB: Die klinische Pharmakologie neuer Benzylisochinolin-Diester-Verbindungen. Unter besonderer Beracksichtigung von Cisatracurium und Mivacurium. Andsthesist (1997) 46:840–849.
- •A review dealing with the pharmacology of muscle relaxants.
- COOK DR, FREEMAN JA, LAI AA et al.:Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renalfailure. Br. 1 Anaesth. (1992)69(2):580–585.
- •A prospective, controlled trial examining the pharmacokinetic aspects of mivacurium.
- MCCLURE JH: Ropivacaine. Br.Anaesth. (1996) 76:300–307.
- ••A review dealing with ropivacaine.
- WHITESIDE JB, WILDSMITH JAW:Developments in local anaesthetic drugs. Br. Anaesth. (2001) 87:27–35.
- •A review dealing with local anaesthetic drugs.
- ROWE WL: Economics and anaesthesia. Anaesthesia (1998) 53:782–788.
- •Editorial comment of economic analysis.
- SPERRY JS: Principles of economicanalysis. Anesthesiology (1997)86(5):1197–1205.
- •Editorial comment of economic analysis.
- FINUCANE BT, GANAPATHY S, CARLI F et al.: Prolonged epidural infusion of Ropivacaine (2 mg/mL) after colonic surgery: the impact of adding fentanyl. Anesth. Analg. (2001) 92:1276–1285.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of ropivacaine versus ropivacaine plus fentanyl.
- MYLES PS, HUNT JO, FLETCHER H et al.: Remifentanil, fentanyl, and cardiac surgery: a double blinded, randomized, controlled trial of costs and outcomes. Anesth. Analg. (2002) 95:805–812.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl.
- OZKOSE Z, COK 0J, TUNCER B, TUFECIOGLU S, YARDIM S: comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA).Clin. Anesth. (2002) 14(3):161–168.
- •A prospective, randomised, controlled trial dealing with cost-minimisation of remifentanil versus fentanyl.
- CASATI A, CAPPELLERI G, BERTI M,FANELLI G, DI BENEDETTO P, TORRI G: Randomized comparison of remifentanil-propofol with a sciatic-femoral nerve block for out-patient knee arthroscopy. Ear: Anaesthesia (2002) 19:109–114.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil-propofol versus sciatic-femoral nerve block.
- ENGOREN M, LUTHER G, FENN-BUDERER N: A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia. Anesth. Analg. (2001) 93:859–864.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl and sufentanil.
- EPPLE J, KUBITZ J, SCHMIDT H et al: Comparative analysis of costs of total intravenous anaesthesia with Propofol and remifentanil versus balanced anaesthesia with isoflurane and fentanyl.Anaesthesia (2001) 18:20–28.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl.
- LOOP T, PRIEBE H-J: Prospective, randomized cost analysis of anesthesia with remifentanil combined with propofol, desflurane, or sevoflurane for otorhinolaryngeal surgery.Acta. Anaesthesia Scand. (2002) 46:1251–1260.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus alfentanil and N20.
- BEERS RA, CALIMLIM JR, UDDOH E, ESPOSITO BE CAMPORESI EM: A comparison of the cost-effectiveness of remifentanil versus fentanyl as an adjuvant to general anesthesia for outpatient gynecologic surgery. Anesth. Analg. (2000) 91:1420–1425.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of remifentanil versus fentanyl.
- HEIDVALL M, HEIN A, DAVIDSON S, JAKOBSSON J: Cost comparison between three different general anaesthetic techniques for elective arthroscopy of the knee. Acta. Anaesthesia Scand. (2000) 44:157–162.
- •A prospective, randomised, controlled trial dealing with cost-minimisation of remifentanil versus fentanyl, alfentanil,Or N20.
- JELLISH WS, LEONETTI JP, AVRAMOV A, FLUDER E, MURDOCH J: Remifentanil-based anestesia versus a propofol technique for otologic surgical procedures. Otolaryngol. Head Neck Sing. (2000)122(2):222–227.
- •A prospective, randomised, controlled trial dealing with cost-minimisation of remifentanil versus fentanyl.
- SUTTNER S, BOLDT J, SCHMIDT C,PIPERS, KUMLE B: Cost analysis of target-controlled infusion-based anesthesia compared with standard anesthesia regimens. Anesth. Analg. (1999) 88:77–82.
- •A prospective, randomised, controlled trial dealing with the cost-minimisation of remifentanil versus fentanyl in combination with N20.
- PUURA ATE, RORARIUS MFG, MANNINEN P, HOPPUT S, BAER GA: The costs of intense neuromuscular block for anesthesia during endolaryngealprocedures due to waiting time.Anesth. Analg. (1999) 88:1335–1339.
- ••A prospective, randomised, controlled trialdealing with the cost-effectiveness of mivacuriurn versus atracuriurn, rocuronium, vecuroniurn, and succinylcoline.
- SPLINTER WM, ISAAC LA: The pharmacoeconomics of neuromuscular blocking drugs: a perioperative cost-minimization strategy in children. Anesth. Analg. (2001) 93:339–344.
- •A prospective, randomised, controlled trial dealing with the cost-minimisation ofmivacuriurn versus atractniurn, rocuroniurn, vecuronium and cisatacurium.